These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2859873)

  • 1. Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.
    Schächter M; Geaney DP; Grahame-Smith DG; Cowen PJ; Elliott JM
    Br J Clin Pharmacol; 1985 Apr; 19(4):453-7. PubMed ID: 2859873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.
    Grahame-Smith DG; Geaney DP; Schachter M; Elliott JM
    Experientia; 1988 Feb; 44(2):142-5. PubMed ID: 2894321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
    Arora RC; Meltzer HY
    Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
    Spigset O; Mjörndal T
    Neuropsychopharmacology; 1997 Apr; 16(4):285-93. PubMed ID: 9094146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
    Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
    Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.
    Laubscher A; Pletscher A; Noll H
    J Pharmacol Exp Ther; 1981 Feb; 216(2):385-9. PubMed ID: 6109775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-[3H]hydroxytryptamine and [3H]lysergic acid diethylamide binding to human platelets.
    Peters JR; Geaney DP; Grahame-Smith DG
    Methods Enzymol; 1992; 215():201-13. PubMed ID: 1435321
    [No Abstract]   [Full Text] [Related]  

  • 9. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
    Spigset O; Mjörndal T
    Psychopharmacology (Berl); 1997 Sep; 133(1):39-42. PubMed ID: 9335078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-hydroxytryptamine receptor of blood platelets.
    Pletscher A; Affolter H
    J Neural Transm; 1983; 57(4):233-42. PubMed ID: 6655466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
    Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
    J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding.
    Wihlbäck AC; Sundström-Poromaa I; Allard P; Mjörndal T; Spigset O; Bäckström T
    Obstet Gynecol; 2001 Sep; 98(3):450-7. PubMed ID: 11530128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.
    Cook EH; Arora RC; Anderson GM; Berry-Kravis EM; Yan SY; Yeoh HC; Sklena PJ; Charak DA; Leventhal BL
    Life Sci; 1993; 52(25):2005-15. PubMed ID: 7684805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human platelet 5-HT2 receptor binding sites re-evaluated: a criticism of current techniques [corrected].
    Steckler T; Rüggeberg-Schmidt K; Müller-Oerlinghausen B
    J Neural Transm Gen Sect; 1993; 92(1):11-24. PubMed ID: 8329169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment.
    Govitrapong P; Chagkutip J; Turakitwanakan W; Srikiatkhachorn A
    Psychiatry Res; 2000 Sep; 96(1):41-50. PubMed ID: 10980325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
    Elliott JM; Kent A
    J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonergic functions and light therapy in seasonal affective disorder.
    Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
    Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status.
    Spigset O; Mjorndal T
    J Clin Psychopharmacol; 1997 Aug; 17(4):292-7. PubMed ID: 9241009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity platelet [3H]LSD binding is decreased in panic disorder.
    Norman TR; Judd FK; Staikos V; Burrows GD; McIntyre IM
    J Affect Disord; 1990 Jun; 19(2):119-23. PubMed ID: 2142698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.